Antidiabetic effect of a nitrosamine-free dephostatin analogue, methoxime-3,4-dephostatin, in db/db mice

Biomedicine and Pharmacotherapy

Volumn 56, Issue 4, 2002, Pages 179-185

  Hiroki, A ^a   Hatakeyama, H ^a   Kawakami, M ^a   Watanabe, T ^b   Takei, I ^a   Umezawa, K ^a  

^a KEIO UNIVERSITY   (Japan)

^b INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

3T3 L1 adipocyte; db db Mouse; Dephostatin; Hepatocyte; Insulin; L6 myocyte; PTP 1B

Indexed keywords

ANTIDIABETIC AGENT; DEOXYGLUCOSE; GLUCOSE; INSULIN; METHOXIME 3,4 DEPHOSTATIN; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG; 4 (ETHYL)(NITROSO)AMINO 3,4 BENZENEDIOL; 4-(ETHYL)(NITROSO)AMINO-3,4-BENZENEDIOL; CATECHOLAMINE; DEPHOSTATIN; HYDROQUINONE DERIVATIVE; N,N' MONOMETHYLENEBIS(PYRIDINIUMALDOXIME); N,N'-MONOMETHYLENEBIS(PYRIDINIUMALDOXIME); NITROSO DERIVATIVE; OXIME;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; LIVER CELL; MOUSE; MYOBLAST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; CHEMISTRY; COMPARATIVE STUDY; METABOLISM;

3T3 CELLS; ANIMALS; CATECHOLAMINES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; GLUCOSE; HYDROQUINONES; HYPOGLYCEMIC AGENTS; MICE; NITROSO COMPOUNDS; OXIMES; RATS;

EID: 0035985966     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(02)00176-2     Document Type: Article

References (27)

1. Pathogenesis of NIDDM. A balanced overview
2. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus
3. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes
4. A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus
5. Differentiating glucose toxicity from glucose desensitization: A new message from the insulin gene
6. Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15
7. The insulin signalling system and the IRS proteins
8. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
9. CAP defines a second signalling pathway required for insulin-stimulated glucose transport
10. Protein-tyrosine phosphatase-1B negatively regulates insulin signaling in l6 myocytes and Fao hepatoma cells
11. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats
12. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus
13. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats
14. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
15. A novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation, and characterization
16. In situ inhibition of protein-tyrosine phosphatase by dephostatin
17. Synthesis and protein tyrosine phosphatase inhibitory activity of dephostatin analogs
18. Enhancement or induction of neurite formation by a protein tyrosine phosphatase inhibitor, 3,4-dephostatin, in growth factor-treated PC12h cells
19. Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes
20. Structure-activity relationship and rational design of 3,4-dephostatin derivatives as protein tyrosine phosphatase inhibitors
21. Development of hormone receptors and hormone responsiveness in vitro. Effect of prolonged insulin treatment on hexose uptake in 3T3-L1 adipocytes
22. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I
23. BMT burgering potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis
24. Preparation of isolated rat liver cells
25. Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells
26. Mechanism by which metformin reduces glucose production in type 2 diabetes
27. NF-kappa B inhibits glucocorticoid and cAMP-mediated expression of the phosphoenolpyruvate carboxykinase gene